optimization, and personalized healthcare outcomes.

Its portfolio includes GenePGx (pharmacogenomics testing), GeneCancer (hereditary cancer risk panel), GeneMind (psychiatric genomics), GeneBaby (pediatric genetics), GeneDiet / GeneNGx (nutrigenomics), and GeneCore (comprehensive genomic profiling). These tests are supported by the company’s proprietary GeneMatrixAI platform, which integrates laboratory automation, clinical decision support tools, and secure cloud-based reporting infrastructure.

Gene Matrix partners with national health systems, private laboratories, universities, and biotechnology organizations to deliver turnkey genomic lab solutions, AI-enabled analytics dashboards, and internationally standardized operating protocols. By combining genomics, artificial intelligence, and scalable laboratory systems, Gene Matrix enables healthcare providers to shift from reactive treatment models to proactive precision medicine.